SILVER SPRING, Md. and SINGAPORE, Singapore, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology provider of cell and gene therapy solutions, announced today its wholly-owned subsidiary, Austrianova Singapore Pte Ltd (ASPL) has just received notice that the U.S. based Personal Care Products Council (PCPC) has assigned the International Nomenclature Cosmetic Ingredient (INCI) name Gel8 (pronounced gelate), to the company’s proprietary cell encapsulation materials.
